TUFTSIN-BEARING LIPOSOMES AS DRUG VEHICLES IN THE TREATMENT OF EXPERIMENTAL ASPERGILLOSIS

Citation
M. Owais et al., TUFTSIN-BEARING LIPOSOMES AS DRUG VEHICLES IN THE TREATMENT OF EXPERIMENTAL ASPERGILLOSIS, FEBS letters, 326(1-3), 1993, pp. 56-58
Citations number
11
Categorie Soggetti
Biophysics,Biology
Journal title
ISSN journal
00145793
Volume
326
Issue
1-3
Year of publication
1993
Pages
56 - 58
Database
ISI
SICI code
0014-5793(1993)326:1-3<56:TLADVI>2.0.ZU;2-X
Abstract
Encapsulation of amphotericin B in tuftsin-bearing liposomes greatly i ncreased its efficacy in treatment of human aspergillosis in mice. Als o, the drug efficacy was significantly increased by pretreating the an imals with drug-free tuftsin-bearing liposomes. These results demonstr ate that macrophage activation can considerably enhance the therapeuti c efficacy of antifungal drugs, like amphotericin B.